Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 109 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SCHERNBERG A, Bockel S, Annede P, Fumagalli I, et al
    Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 16. pii: S0360-3016(18)30967.
    PubMed     Text format     Abstract available


  2. LI R, Shinde A, Chen YJ, Amini A, et al
    Survival benefit of adjuvant brachytherapy after hysterectomy with positive surgical margins in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 8. pii: S0360-3016(18)30929.
    PubMed     Text format     Abstract available


    May 2018
  3. GROVER S, Bvochora-Nsingo M, Yeager A, Chiyapo S, et al
    Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
    Int J Radiat Oncol Biol Phys. 2018;101:201-210.
    PubMed     Text format     Abstract available


    March 2018
  4. HAN K, Shek T, Vines D, Driscoll B, et al
    Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with (18)F-Fluoroazomyin Arabinoside.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30329.
    PubMed     Text format     Abstract available


    February 2018
  5. MANEA E, Escande A, Bockel S, Khettab M, et al
    Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30251.
    PubMed     Text format     Abstract available


  6. KALASH R, Glaser SM, Rangaswamy B, Horne ZD, et al
    Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2018 Feb 6. pii: S0360-3016(18)30216.
    PubMed     Text format     Abstract available


    December 2017
  7. VULPE H, Asamoah FA, Maganti M, Vanderpuye V, et al
    External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34493.
    PubMed     Text format     Abstract available


    November 2017
  8. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    PubMed     Text format     Abstract available


  9. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    PubMed     Text format     Abstract available


  10. MAHANTSHETTY U, Krishnatry R, Hande V, Jamema S, et al
    Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Int J Radiat Oncol Biol Phys. 2017;99:608-617.
    PubMed     Text format     Abstract available


  11. GLASER S, Mahantshetty U, Lee L, Klopp A, et al
    Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward.
    Int J Radiat Oncol Biol Phys. 2017;99:505-509.
    PubMed     Text format    


    September 2017
  12. BAUER-NILSEN K, Hill C, Trifiletti DM, Libby B, et al
    Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2017 Sep 14. pii: S0360-3016(17)33855.
    PubMed     Text format     Abstract available


  13. FIELDS EC, Melvani R, Hajdok G, D'Souza D, et al
    A Multi-institution, Retrospective Analysis of Cervix Intracavitary Brachytherapy Treatments. Part 1: Is EQD2 Good Enough for Reporting Radiobiological Effects?
    Int J Radiat Oncol Biol Phys. 2017;99:219-226.
    PubMed     Text format     Abstract available


    August 2017
  14. JHAWAR S, Hathout L, Elshaikh MA, Beriwal S, et al
    Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
    Int J Radiat Oncol Biol Phys. 2017;98:1132-1141.
    PubMed     Text format     Abstract available


  15. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    PubMed     Text format     Abstract available


    July 2017
  16. JOO J, Shin HJ, Park B, Park SY, et al
    Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:654-661.
    PubMed     Text format     Abstract available


    April 2017
  17. RAMLOV A, Pedersen EM, Rohl L, Worm E, et al
    Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:1032-1039.
    PubMed     Text format     Abstract available


  18. BINGHAM B, Orton A, Boothe D, Stoddard G, et al
    Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Int J Radiat Oncol Biol Phys. 2017;97:1040-1050.
    PubMed     Text format     Abstract available


    March 2017
  19. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:797-805.
    PubMed     Text format     Abstract available


  20. MELL LK, Sirak I, Wei L, Tarnawski R, et al
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Int J Radiat Oncol Biol Phys. 2017;97:536-545.
    PubMed     Text format     Abstract available


    January 2017
  21. LI N, Carmona R, Sirak I, Kasaova L, et al
    Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:164-172.
    PubMed     Text format     Abstract available


    November 2016
  22. HO JC, Allen PK, Bhosale PR, Rauch GM, et al
    Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016 Nov 17. pii: S0360-3016(16)33438.
    PubMed     Text format     Abstract available


  23. WILLIAMSON CW, Green G, Noticewala SS, Li N, et al
    Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:801-807.
    PubMed     Text format     Abstract available


  24. SWANICK CW, Castle KO, Vedam S, Munsell MF, et al
    Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:793-800.
    PubMed     Text format     Abstract available


    October 2016
  25. HAN DY, Safigholi H, Soliman A, Ravi A, et al
    Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Int J Radiat Oncol Biol Phys. 2016;96:440-8.
    PubMed     Text format     Abstract available


  26. LI N, Noticewala SS, Williamson CW, Shen H, et al
    ATLAS-Based Active Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  27. ARISTOPHANOUS M, Cardenas CE, Ho JC, Lee JS, et al
    Development of a Radiomics-Based Survival Prediction Model for Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  28. ONAL C, Guler OC, Akkus Yildirim B
    Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  29. SINGH R, Chopra S, Engineer R, Kannan S, et al
    Impact of Cumulative Radiation Doses to Vagina on Late Toxicity and Sexual Quality of Life in Patients Treated With Postoperative Adjuvant Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  30. TAKATOSHI T, Uchida N, Tanino T, Sakaguchi H, et al
    Apparent Diffusion Coefficients (ADCs) in Diffusion-Weighted 3.0 Tesla MR Imaging Is Useful in Predicting Therapeutic Response to Concurrent Chemoradiation Therapy in Patients With Uterine Cervical Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  31. HONG JC, Foote J, Broadwater G, Sosa J, et al
    Total Treatment Duration for Cervical Cancer: Is 55 Days Still the Goal in the Era of Concurrent Chemotherapy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  32. HONG JH, Lin SM, Ku HY, Liu TW, et al
    The Influence of Hospital Volume on Disease Outcomes of Advanced Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  33. MELL LK, Saenz CC, Yashar CM, McHale MT, et al
    Phase 1 Trial of Bone Marrow Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Gemcitabine in Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  34. RODIN D, Hanna TP, Burger E, Zubizarreta E, et al
    Global Access to Radiation Therapy for Cervical Cancer: The Cost of Inaction.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  35. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  36. NOMDEN C, de Leeuw AA, Tanderup K, Lindegaard JC, et al
    Nodal Failure After Chemoradiation and Magnetic Resonance Imaging Guided Adaptive BT in Cervical Cancer: A Subanalysis Within Embrace.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  37. XIE L
    Acute Hematologic Toxicity and Long-Term Treatment Outcome of Concurrent Chemoradiation Therapy With Weekly Cisplatin and Paclitaxel in Patients With FIGO Stage IB2-IIIb Intact Cervical Cancer: A Single-Center Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  38. XIE C, Jin X, Li L
    Phase 3 Randomized Trial of Comparing Chemoradiation Therapy Versus Radiation Therapy Alone in Lymph Node-Negative Patients With Early-Stage Cervical Cancer Following Radical Hysterectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  39. TSUJII K, Ueda Y, Isono M, Miyazaki M, et al
    Dosimetric Impact of Rotational Setup Errors for Cervical Cancer Patients With Postoperative Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  40. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Longitudinal Assessment of Quality of Life Following Intensity Modulated Radiation Therapy for Cervical Cancer: Preliminary Analysis of the INTERTECC Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  41. DATTA NR, Rogers S, Hutton B, Klingbiel D, et al
    Network Meta-Analysis in Locally Advanced Cervical Cancer: Evaluation of Outcomes With Chemoradiation Therapy or Thermoradiation Therapy Versus Radiation Therapy Alone.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  42. FIORENTINO A, Giaj Levra N, Ricchetti F, Fersino S, et al
    Weekly Cisplatin and Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  43. CHAN KY, Benwell Q, Schneider K, Ang M, et al
    A Canadian Experience: Current State and Challenges of Magnetic Resonance--Guided Cervical Cancer Brachytherapy in Ontario.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  44. KIM J, Lee J, Lee KJ, Kim Y, et al
    Survival Outcome of Cervical Cancer Patients Staged With Magnetic Resonance Imaging.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  45. GULYBAN A, Baiwir M, Nicolas S, Nguyen PV, et al
    Actual Delivered Dose for CTV and Bladder During External Beam Radiation Therapy of Locally Advanced Cervical Cancer: Deformable Dose Accumulation Quality Assurance and Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  46. KIM Y, Liu Y, Flynn RT, Wu X, et al
    Expected Clinical Outcome Improvement of Rotating-Shield Brachytherapy (RSBT) for Cervical Cancer: Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) Evaluations.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  47. KUO HC, Mehta KJ, Yaparpalvi R, Garg M, et al
    Can Intensity Modulated Proton Therapy (IMPT) Be an Alternative to Image Guided Brachytherapy (IGBT) for Locally Advanced Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  48. RAI B, Miriyala R, Ghoshal S, Ballari NR, et al
    Margins Around the Involved Pelvic Lymph Nodes for Planning Simultaneous Integrated Boost in Patients With Cervical Cancer Undergoing Pelvic Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  49. CHEN W, Bai P, Pan J, Zheng X, et al
    To Assess the Changes of Volume and Spatial Location of Target Area During Cone Beam Computed Tomography for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  50. KAWASHIMA A, Isohashi F, Mabuchi S, Okubo H, et al
    Early Outcomes and Dose-Volume Analysis for Patients With Cervical Cancer Treated With Computed Tomography-Based Treatment Planning in Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  51. CHENG G, He M, Zhao H, Zhang N, et al
    Radical Hysterectomy With Adjuvant Radiation Therapy Versus Definitive Radiation Therapy for International Federation of Gynecology and Obstetrics Stage IIb Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  52. OGINO I, Kitagawa M, Watanabe S, Aoki S, et al
    Calcium Phosphate Cement Paste Injection as a Marker of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  53. ISOHASHI F, Mabuchi S, Yoshioka Y, Tamari K, et al
    Postoperative Whole-Pelvic Intensity Modulated Radiation Therapy in Surgically Treated Cervical Cancer Patients With Adverse Risk Factors.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  54. DANG Y, Li X, Liu S, Wei L, et al
    A Retrospective Study of 344 Patients With FIGO Stage IIB Cervical Carcinoma After Neoadjuvant Chemoradiation Therapy in Cervical Cancer: Pelvic Lymph Node Dissection Should Be Tailored.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  55. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  56. ORWAT K, Mendoza A, Young Pierce J, Cooper SL, et al
    Predictive Value of High-Risk Human Papillomavirus and Positron Emission Tomography/Computed Tomography for Local Control After Chemoradiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  57. KUROKAWA M, Iwai Y, Togasaki G, Kanazawa A, et al
    Postoperative Radiation Therapy for Cervical Cancer: Three-Dimensional Conformal Radiation Therapy (3DCRT) Versus Intensity Modulated Radiation Therapy (IMRT).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  58. TAGGAR A, Phan T, Traptow L, Banerjee RN, et al
    Cervical Cancer Brachytherapy in Canada: A Focus on Interstitial Brachytherapy Utilization.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  59. SEKII S, Murakami N, Nakamura S, Kashihara T, et al
    Supplementary Bladder Reference Point of High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer: Feedback 3-Dimension to 2-Dimension.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  60. KHULLAR K, Sudhoff M, Elson JK, Herzog T, et al
    A Comparison of Dosimetric Parameters in PET-Based Active Bone Marrow Volume and Total Bone Volume in Prediction of Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  61. WANG X, Wang P, Li J, Yuan K, et al
    Image Guided Radiation Therapy Boost in Combination With High-Dose-Rate Intracavitary Brachytherapy for the Treatment of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  62. SHARMA DN, Gandhi AK, Adhikari N
    Definitive Radiation Therapy of Locally Advanced Cervical Cancer Initially Treated With Palliative Hypofractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  63. NEMOTO MW, Ikeda Y, Ii N, Toita T, et al
    Multi-Institutional Comparative Study of MRI Technique in Cervical Cancer Image-Based Brachytherapy (IGBT): 3D MRI With High Sampling Efficiency Versus Conventional 2D Multiplanar MRI.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  64. CHENG JY, Huang EY, Hsu SN, Wang CJ, et al
    Simultaneous Integrated Boost (SIB) of the Parametrium and Cervix in Radiation Therapy for Cervical Cancer: A Dosimetric Study of a New Novel Approach.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  65. SONG Y, Chen X, Erickson BA, Li A, et al
    Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  66. TANAKA H, Kato A, Kawaguchi M, Yamaguchi T, et al
    Pelvic Insufficiency Fractures After Whole-Pelvic Irradiation for Uterine Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  67. LIN SM, Hong JH, Ku HY, Liu TW, et al
    The Prognostic Impact of Overall Treatment Time on Disease Outcomes of Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  68. BECKTA JM, Wan W, Quinn BA, Fields EC, et al
    Socioeconomic Disparities in Cervical Cancer Patients Presenting to a Tertiary Care Facility.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  69. MAHMOUD OM, Green WR, Gabel M, Gibbon D, et al
    Replicating Landoni's Study in the Era of Chemotherapy: Postoperative or Radical Concurrent Chemoradiation Therapy in Early-Stage Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  70. YUCE SARI S, Guler OC, Gultekin M, Onal C, et al
    Adjuvant Small Pelvic Radiation Therapy in Cervical Cancer Patients With Minor Risk Factors.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  71. AZEVEDO TL, Hess CB, Kamrava M, Tavares Guerreiro Fregnani JH, et al
    Predicting the Necessity of Adding Catheters to Intracavitary Brachytherapy for Women Undergoing Definitive Chemoradiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  72. MANLEY HJ, O'Donnell BP, Echeverria A, Hsieh G, et al
    Treatment Compliance With Radiation for Women treated for Cervical Cancer in a Safety Net Health System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  73. PAUL AG, Miller SR 2nd, Nalichowski A, Abrams J, et al
    Dosimetric Evaluation of Point A and Volume-Based High-Dose-Rate Plans: A Single-Institution Study on Adaptive Brachytherapy Planning for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  74. CHIN RI, Tran L, Thomas MA, Siegel B, et al
    Changes in Cervical Cancer FDG Uptake Heterogeneity After Chemoradiation: Association With Tumor Recurrence and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  75. ZHANG Y, Shi M, Wei LC, Li J, et al
    Safety and Short-Term Effect of Docetaxel and Cisplatin Chemotherapy Concurrent With Pelvic Radiation Therapy in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  76. SASIDHARAN A, Mahantshetty UM, Engineer R, Chopra S, et al
    Outcome After First Relapse in Patients With Locally Advanced Cervical Cancer Treated With Radical Radio (Chemo) Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  77. ROBIN TP, Amini A, Behbakht K, Fisher CM, et al
    Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  78. MAHMOUD OM, Gabel M, Jhawar S, Gibbon D, et al
    How Important Is Chemotherapy Timing and Treatment Duration in the Adjuvant Management of Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  79. ACHARYA S, Grigsby PW
    Access to Health Care and Disparities in Cervical Cancer Diagnosis, Treatment, and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  80. WILLIAMSON CW, Green G, Noticewala S, Li N, et al
    Prospective Validation of a High-Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  81. MAHMOUD OM, Gabel M, Gibbon D, Leiser A, et al
    Can Chemotherapy Boost the Survival Benefit of Adjuvant Radiation Therapy in Early-Stage Cervical Cancer With Intermediate Risk Factors: A Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    April 2016
  82. ZOLCIAK-SIWINSKA A, Gruszczynska E, Bijok M, Jonska-Gmyrek J, et al
    Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 24. pii: S0360-3016(16)30136.
    PubMed     Text format     Abstract available


  83. SUSKO M, Craciunescu O, Meltsner S, Yang Y, et al
    Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;94:1099-105.
    PubMed     Text format     Abstract available


    March 2016
  84. GROVER S, Harkenrider MM, Cho LP, Erickson B, et al
    Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society.
    Int J Radiat Oncol Biol Phys. 2016;94:598-604.
    PubMed     Text format     Abstract available


  85. POTTER R, Federico M, Sturdza A, Fotina I, et al
    Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;94:588-97.
    PubMed     Text format     Abstract available


    February 2016
  86. MARNITZ S, Martus P, Kohler C, Stromberger C, et al
    Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecolog
    Int J Radiat Oncol Biol Phys. 2016;94:243-53.
    PubMed     Text format     Abstract available


    January 2016
  87. BASU P, Jenson AB, Majhi T, Choudhury P, et al
    Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;94:102-10.
    PubMed     Text format     Abstract available


    December 2015
  88. KIRCHHEINER K, Potter R, Tanderup K, Lindegaard JC, et al
    Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
    Int J Radiat Oncol Biol Phys. 2015 Dec 29. pii: S0360-3016(15)27202.
    PubMed     Text format     Abstract available


  89. TRIFILETTI DM, Swisher-McClure S, Showalter TN, Hegarty SE, et al
    Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Int J Radiat Oncol Biol Phys. 2015;93:1032-1044.
    PubMed     Text format     Abstract available


    November 2015
  90. YOSHIDA K, Jastaniyah N, Sturdza A, Lindegaard J, et al
    Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
    Int J Radiat Oncol Biol Phys. 2015;93:788-96.
    PubMed     Text format     Abstract available


  91. LANGERAK T, Mens JW, Quint S, Bondar L, et al
    Cervix Motion in 50 Cervical Cancer Patients Assessed by Daily Cone Beam Computed Tomographic Imaging of a New Type of Marker.
    Int J Radiat Oncol Biol Phys. 2015;93:532-9.
    PubMed     Text format     Abstract available


    September 2015
  92. MILOSEVIC MF, Townsley CA, Chaudary N, Clarke B, et al
    Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study.
    Int J Radiat Oncol Biol Phys. 2015 Sep 18. pii: S0360-3016(15)03320.
    PubMed     Text format     Abstract available


  93. GOVARDHAN HB, Khaleel I, Sridhar P, Siddanna P, et al
    Chemoradiation followed by surgery for advanced cervical cancer: In Regard to Ferrandina et al.
    Int J Radiat Oncol Biol Phys. 2015;93:213.
    PubMed     Text format    


  94. FERRANDINA G
    In Reply to Govardhan et al.
    Int J Radiat Oncol Biol Phys. 2015;93:213-4.
    PubMed     Text format    


    August 2015
  95. GRANT SR, Walker GV, Koshy M, Shaitelman SF, et al
    Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2015 Aug 28. pii: S0360-3016(15)03193.
    PubMed     Text format     Abstract available


  96. TINKLE CL, Weinberg V, Chen LM, Littell R, et al
    Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Int J Radiat Oncol Biol Phys. 2015;92:1093-100.
    PubMed     Text format     Abstract available


  97. JAHN F, Riesner A, Jahn P, Sieker F, et al
    Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
    Int J Radiat Oncol Biol Phys. 2015;92:1101-7.
    PubMed     Text format     Abstract available


    July 2015
  98. HARKENRIDER MM, Alite F, Silva SR, Small W Jr, et al
    Image-Based Brachytherapy for the Treatment of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:921-34.
    PubMed     Text format     Abstract available


  99. LIN LL, Kirk M, Scholey J, Taku N, et al
    Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Jul 11. pii: S0360-3016(15)02955.
    PubMed     Text format     Abstract available


  100. GAFFNEY DK, Suneja G, Ryu SY, McCormick M, et al
    The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup.
    Int J Radiat Oncol Biol Phys. 2015;92:506-8.
    PubMed     Text format    


    June 2015
  101. SMITH GL, Jiang J, Giordano SH, Meyer LA, et al
    Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011.
    Int J Radiat Oncol Biol Phys. 2015;92:260-7.
    PubMed     Text format     Abstract available


  102. XIE LX, Xue RL, Xie WJ
    In regard to Vargo et al.
    Int J Radiat Oncol Biol Phys. 2015;92:475.
    PubMed     Text format    


  103. VARGO JA, Beriwal S
    In reply to Xie et al.
    Int J Radiat Oncol Biol Phys. 2015;92:475-6.
    PubMed     Text format    


    May 2015
  104. SIMPSON DR, Scanderbeg DJ, Carmona R, McMurtrie RM, et al
    Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2015 May 4. pii: S0360-3016(15)00465.
    PubMed     Text format     Abstract available


    April 2015
  105. AGUILERA TA, Giaccia AJ
    The end of the hypoxic EPOch.
    Int J Radiat Oncol Biol Phys. 2015;91:895-7.
    PubMed     Text format    


    March 2015
  106. GILL BS, Beriwal S
    In regard to Dyk et al.
    Int J Radiat Oncol Biol Phys. 2015;91:881-2.
    PubMed     Text format    


    January 2015
  107. ERICKSON B
    Evolving traditions on the technology journey.
    Int J Radiat Oncol Biol Phys. 2015;91:14-6.
    PubMed     Text format    


  108. OHRI N, Rapkin BD, Guha D, Haynes-Lewis H, et al
    Predictors of radiation therapy noncompliance in an urban academic cancer center.
    Int J Radiat Oncol Biol Phys. 2015;91:232-8.
    PubMed     Text format     Abstract available


    November 2014
  109. XIE WJ, Wu X, Xue RL, Lin XY, et al
    More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix.
    Int J Radiat Oncol Biol Phys. 2014 Nov 5. pii: S0360-3016(14)04095.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: